Pages

Monday, 11 March 2019

Here's Why bluebird bio Gained 16.3% in February


Here's Why bluebird bio Gained 16.3% in February



The biopharma announced fourth-quarter 2018 operating results and reminded investors of its deep late-state pipeline.

Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)